These features include age, smoking, diabetes, BSA, BMI, tumor staging, tumor location, lung metastasis, ALB, CEA, TP53 gene mutation, and the number of chemotherapy cycles. This evidence concerns the gene CEACAM5 and diabetes mellitus.